Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 340-348

  Mascola, John R ^a   Snyder, Stuart W ^b   Weislow, Owen S ^b   Belay, Seifu M ^b   Belshe, Robert B ^b   Schwartz, David H ^b   Clements, Mary Lou ^b   Dolin, Raphael ^b   Graham, Barney S ^b   Gorse, Geoffrey J ^b   Keefer, Michael C ^b   McElrath, M Juliana ^b   Walker, Mary Clare ^b   Wagner, Kenneth F ^b   McNeil, John G ^b   McCutchan, Francine E ^b   Burke, Donald S ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ENVELOPE PROTEIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS ENVELOPE;

EID: 19144365910     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.340     Document Type: Article

References (11)

1. Hammon W McD, Coriel LL, Wehrle PF. Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. JAMA 1953;151:1272-85.
2. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988;239:476-81.
3. de Noronha F, Schafer W, Essex M, Bolognesi DP. Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus. Virology 1978;85:617-21.
4. Schwartz H, Fischinger PJ, Ihle JN, et al. Properties of mouse leukemia viruses, XVI: suppression of spontaneous fatal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein g71. Virology 1979;93:159-74.
5. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162:1036-42.
6. Suss J, Sinnecker H. Immune reactions against rabies viruses - infection and vaccination. Exp Pathol 1991;42:1-9.
7. Smithbum KC, Mahaffy AF. Immunization against yellow fever. Studies on the time of development and the duration of induced immunity. Am J Trop Med Hyg 1945;25:217-23.
8. Frank AL, Taber LH, Glezen PW, Geiger EA, McIlwain S, Paredes A. Influenza B virus infections in the community and the family: the epidemics of 1976-1977 and 1979-1980 in Houston, Texas. Am J Epidemiol 1983;118:313-25.
9. Lasky LA, Groopman JE, Fennie CW, et al. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science 1986;233:209-12.
10. Steimer KS, Haigwood NL. Immunization of primates with native, recombinant HIV-SF2 gp120 generates broadly effective neutralizing antibodies directed to conformational epitopes. AIDS Res Hum Retroviruses 1992;8:1391.
11. Javaherian K, Langlois AJ, McDanal C, et al. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci USA 1989;86:6768-72.